Dr. Harlan Andrew Pinto, MD is a Internal Medicine Physician - Hematology practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Yale University School of Medicine | Medical Degree | 1983 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Massachusetts General Hospital | 1986 | |
| Internship - Massachusetts General Hospital | 1984 | |
| Internship - Massachusetts General Hospital | 1984 | |
| Fellowship - Stanford University School of Medicine,Stanford, Ca, United States | 1991 |
| Certification | Cert. Body | Year |
|---|---|---|
Sub-Specialty: Medical Oncology | Internal Medicine | 1991 |
| Internal medicine | Internal Medicine | 1986 |
| Position | Organization | Time |
|---|---|---|
| Associate Professor of Medicine (Oncology) | the PAVAHCS and, by courtesy of Otolaryngology - Head & Neck Surgery at SUMC | Present |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N | INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX | 2011 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER | 2010 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | In vivo H-1 magnetic resonce spectroscopy of lactate in patients with Stage IV head | 2008 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Excellent local control with stereotactic radiotherapy boost after exterl beam radiotherapy | 2008 |
| Other Publication | JOURL OF THE TIOL CANCER INSTITUTE | Improved survival of patients with human papillomavirus-positive head | 2008 |
| Other Publication | HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N | Evaluation of patterns of failure | 2007 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Clinical role of F-18-FDG PET | 2007 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Plasma osteopontin is an independent prognostic marker for head and neck cancers | 2006 |
| Other Publication | HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N | Advanced-staged tonsillar squamous carcinoma | 2006 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase II double-blind r | 2004 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Improved local control with stereotactic radiosurgical boost | 2003 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Comparison of the comet assay | 2003 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Estimating D repair by sequential evaluation of head | 2002 |
| Other Publication | AMERICAN JOURL OF NEURORADIOLOGY | In vivo H-1 MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen | 2000 |
| Other Publication | Neoplasia | D damage measured by the comet assay in head and neck cancer patients treated with tirapazamine. | 1999 |
| Other Publication | Tate, D. J., Adler, J. R., Chang, S. D., Marquez, S., Eulau, S. M., Fe | Stereotactic radiosurgical boost following radiotherapy in primary sopharyngeal carcinoma | 1999 |
| Other Publication | HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N | Tissue oxygen distribution in head and neck cancer patients | 1999 |
| Other Publication | AMERICAN JOURL OF SURGERY | Magement of the clinically positive neck in organ preservation for advanced head and neck cancer | 1998 |
| Other Publication | SEMIRS IN ONCOLOGY | Adjuvant and neoadjuvant treatment of head and neck cancers: The next chapter | 1995 |
| Other Publication | Macdold JS, Haller DG, Mayer RJ (eds), Manual of Oncologic Therapeutic | Head and neck cancers. | 1995 |
| Other Publication | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND | INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX | 2011 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER | 2010 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | In vivo H-1 magnetic resonance spectroscopy of lactate in patients with Stage IV head | 2008 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy | 2008 |
| Other Publication | JOURNAL OF THE NATIONAL CANCER INSTITUTE | Improved survival of patients with human papillomavirus-positive head | 2008 |
| Other Publication | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND | Evaluation of patterns of failure | 2007 |
| Other Publication | JOURNAL OF NUCLEAR MEDICINE | Clinical role of F-18-FDG PET | 2007 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Plasma osteopontin is an independent prognostic marker for head and neck cancers | 2006 |
| Other Publication | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND | Advanced-staged tonsillar squamous carcinoma | 2006 |
| Other Publication | CANCER | Mature results from a randomized phase II trial of cisplatin plus 5 | 2006 |
| Other Publication | LARYNGOSCOPE | Positron-emission tomography for surveillance of head and neck cancer | 2005 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Long-term results of 100 consecutive comprehensive neck dissections | 2004 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Phase II double-blind r | 2004 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Improved local control with stereotactic radiosurgical boost | 2003 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Comparison of the comet assay | 2003 |
| Other Publication | CLINICAL CANCER RESEARCH | Identification of osteopontin as a prognostic plasma marker for head | 2003 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Estimating DNA repair by sequential evaluation of head | 2002 |
| Other Publication | AMERICAN JOURNAL OF NEURORADIOLOGY | In vivo H-1 MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen | 2000 |
| Other Publication | Neoplasia | DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine. | 1999 |
| Other Publication | Tate, D. J., Adler, J. R., Chang, S. D., Marquez, S., Eulau, S. M., Fe | Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma | 1999 |
| Other Publication | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND | Tissue oxygen distribution in head and neck cancer patients | 1999 |
| Other Publication | LARYNGOSCOPE | Pretreatment and midtreatment measurement of oxygen tension levels in head and neck cancers | 1998 |
| Other Publication | AMERICAN JOURNAL OF SURGERY | Management of the clinically positive neck in organ preservation for advanced head and neck cancer | 1998 |
| Other Publication | Newman, J. P., Terris, D. J., Pinto, H. A., Fee, W. E., Goode, R. L., | Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer | 1997 |
| Other Publication | SEMINARS IN ONCOLOGY | Adjuvant and neoadjuvant treatment of head and neck cancers: The next chapter | 1995 |
| Other Publication | Cancer treatment and research | Distant metastases from head and neck squamous cancer: the role of adjuvant chemotherapy. | 1995 |
| Other Publication | Macdonald JS, Haller DG, Mayer RJ (eds), Manual of Oncologic Therapeut | Head and neck cancers. | 1995 |
| Other Publication | : Brian MC and Carbone PP (eds), Current Therapy in Hematology-Oncolog | Head and neck cancer - combined modality therapy and chemotherapy. | |
| Other Publication | HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | CHEMOTHERAPY FOR RECURRENT AND METASTATIC HEAD AND NECK-CANCER | 1991 |
Years In Practice: 35 (started in 1990)
Accepts New Patients: Yes
Dr. Harlan Andrew Pinto, MD has not yet listed the medications that he commonly prescribes.
